Protocol No.: A051901

Title

Phase I Trial of Methotrexate, Rituximab, Lenalidomide, and Nivolumab (NIVO-MR2) Induction followed by Lenalidomide and Nivolumab Maintenance in Primary CNS Lymphoma

Principal Investigator

Aulakh, Sonikpreet

Phase

I

Age Group

Adult

Applicable Disease Sites

Brain Cancer

Lymphoma

Participating Institution

Mary Babb Randolph Cancer Center

Contact

Syed Abdul Mannan Shah

Clinical Research Specialist

Phone: +1 304-293-1683

Email: syedabdulmannan.shah@hsc.wvu.edu

View on ClinicalTrials.gov